Avanos Medical (AVNS)
(Delayed Data from NYSE)
$18.10 USD
+0.25 (1.40%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $18.09 -0.01 (-0.06%) 7:58 PM ET
3-Hold of 5 3
A Value D Growth B Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
AVNS 18.10 +0.25(1.40%)
Will AVNS be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for AVNS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVNS
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
Why Is Integra (IART) Down 4% Since Last Earnings Report?
AVNS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Avanos (AVNS) Q4 Earnings Lag Estimates, Margins Contract
New Strong Sell Stocks for January 16th
New Strong Sell Stocks for January 12th
Other News for AVNS
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Commit To Buy Avanos Medical At $10, Earn 57% Annualized Using Options
What's Driving Establishment Labs Holdings Inc's Surprising 93% Stock Rally?
Atrion Corporation Is Overvalued For The Direction Fundamentals Are Heading
Avanos Medical Inc's SVP - CFO Michael Greiner Sells 8,000 Shares